Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

E.H.M. Machielsen; A.S. Beduin; N. Dekker; R.S. Kahn; D.H. Linszen; J. van Os; D. Wiersma; R. Bruggeman; W. Cahn; L. de Haan; L. Krabbendam; x. Genetic Risk and Outcome of Psychosis (GROUP) Investigators; X et al.; I. Myin-Germeys

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

Translated title of the contribution: Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

E.H.M. Machielsen, A.S. Beduin, N. Dekker, R.S. Kahn, D.H. Linszen, J. van Os, D. Wiersma, R. Bruggeman, W. Cahn, L. de Haan, L. Krabbendam, x. Genetic Risk and Outcome of Psychosis (GROUP) Investigators, X et al., I. Myin-Germeys

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine
Original language	Undefined/Unknown
Pages (from-to)	189-195
Number of pages	7
Journal	Journal of Psychopharmacology
Volume	26
Issue number	1
Publication status	Published - 2012

Keywords

Econometric and Statistical Methods: General
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21768161

Cite this

Machielsen, E. H. M., Beduin, A. S., Dekker, N., Kahn, R. S., Linszen, D. H., van Os, J., Wiersma, D., Bruggeman, R., Cahn, W., de Haan, L., Krabbendam, L., Genetic Risk and Outcome of Psychosis (GROUP) Investigators, X., et al., X., & Myin-Germeys, I. (2012). Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology, 26(1), 189-195. http://www.ncbi.nlm.nih.gov/pubmed/21768161

@article{a4b7ef4257df4200a3205f8541dccae9,

title = "Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine",

keywords = "Econometric and Statistical Methods: General, Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "E.H.M. Machielsen and A.S. Beduin and N. Dekker and R.S. Kahn and D.H. Linszen and {van Os}, J. and D. Wiersma and R. Bruggeman and W. Cahn and {de Haan}, L. and L. Krabbendam and {Genetic Risk and Outcome of Psychosis (GROUP) Investigators}, x. and {et al.}, X and I. Myin-Germeys",

year = "2012",

language = "Undefined/Unknown",

volume = "26",

pages = "189--195",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "SAGE Publications Ltd",

number = "1",

}

Machielsen, EHM, Beduin, AS, Dekker, N, Kahn, RS, Linszen, DH, van Os, J, Wiersma, D, Bruggeman, R, Cahn, W, de Haan, L, Krabbendam, L, Genetic Risk and Outcome of Psychosis (GROUP) Investigators, X, et al., X & Myin-Germeys, I 2012, 'Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine', Journal of Psychopharmacology, vol. 26, no. 1, pp. 189-195. <http://www.ncbi.nlm.nih.gov/pubmed/21768161>

TY - JOUR

T1 - Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine

AU - Machielsen, E.H.M.

AU - Beduin, A.S.

AU - Dekker, N.

AU - Kahn, R.S.

AU - Linszen, D.H.

AU - van Os, J.

AU - Wiersma, D.

AU - Bruggeman, R.

AU - Cahn, W.

AU - de Haan, L.

AU - Krabbendam, L.

AU - Genetic Risk and Outcome of Psychosis (GROUP) Investigators, x.

AU - et al., X

AU - Myin-Germeys, I.

PY - 2012

Y1 - 2012

KW - Econometric and Statistical Methods: General

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 0269-8811

VL - 26

SP - 189

EP - 195

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

IS - 1

ER -